This article is more than 5 years old. Information may no longer be current.
Neuro-oncologist joins NYU center
Click Here to Manage Email Alerts
Howard A. Fine
Howard A. Fine, MD, has been appointed the Anne Murnick Cogan and David H. Cogan Professor of Oncology at NYU Langone Medical Center.
Fine also will serve as chief of the division of hematology and medical oncology, director of the Brain Tumor Center, and deputy director of the NYU Cancer Institute.
Fine previously served as chief of the Neuro-Oncology Branch at NCI.
In his new role, he will direct clinical programs in solid tumor oncology, developmental therapeutics, malignant hematology and experimental hematology.
Fine completed his internship and his residency in internal medicine at the Hospital of The University of Pennsylvania. He completed a fellowship in medical oncology at the Dana-Farber Cancer Institute in Boston. He joined NIH in 2000.
“We are delighted to welcome Dr. Fine to the NYU Langone faculty. As one of today’s leading neuro-oncologists and a visionary leader, he brings a wealth of expertise and experience in research to treat brain tumors of adults and children,” William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics and director of the NYU Cancer Institute, said in a press release. “He will continue to build on the world-class care our patients have already come to expect us to deliver.”